By Professor Ric Day

Journal articles

Wiley J; Westbrook M; Long J; Greenfield JR; Day RO; Braithwaite J, 2013, 'Multidisciplinary diabetes team care: The experiences of young adults with Type 1 diabetes', Health Expectations, http://dx.doi.org/10.1111/hex.12170

Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs (NSAIDs)', BMJ, 346, pp. Article No. f3195, http://dx.doi.org/10.1136/bmj.f3195

Ghinea N; Lipworth W; Little M; Kerridge I; Day R, 2013, 'Overcoming Entrenched Disagreements: the Case of Misoprostol for Post-Partum Haemorrhage', Developing World Bioethics, pp. n/a - n/a, http://dx.doi.org/10.1111/dewb.12040

Duong JK; Kumar SS; Carl m kirkpatrick CM; Greenup LC; Arora M; Lee TC; Timmins P; Graham GG; Furlong TJ; Greenfield JR; Williams KM; Day RO, 2013, 'Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes: Simulation of doses according to renal function', Clinical Pharmacokinetics, 52, pp. 373 - 384, http://dx.doi.org/10.1007/s40262-013-0046-9

Harris IA; Day RO, 2013, 'PRECISE - pregabalin in addition to usual care for sciatica: study protocol for a randomised controlled trial', Trials, 14, pp. 213, http://dx.doi.org/10.1186/1745-6215-14-213

Gallego B; Runciman WB; Perez-Concha O; Liaw S; Day RO; Dunn AG; Coiera E; Liaw T, 2013, 'The management of severe hypertension in Australian general practice', BMC health services research, 13, pp. 414, http://dx.doi.org/10.1186/1472-6963-13-414

Graham GG; Davies MJ; Day RO; Mohamudally A; Scott KF, 2013, 'The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.', Inflammopharmacology, 21, pp. 201 - 232, http://dx.doi.org/10.1007/s10787-013-0172-x

Day RO; Kannangara DRW; Hayes JM; Furlong TJ, 2012, 'Successful use of allopurinol in a patient on dialysis.', BMJ case reports, 2012

Runciman WB; Hunt TD; Hannaford NA; Hibbert PD; Westbrook JI; Coiera EW; Day RO; Hindmarsh DM; McGlynn EA; Braithwaite J, 2012, 'CareTrack: assessing the appropriateness of health care delivery in Australia REPLY', MEDICAL JOURNAL OF AUSTRALIA, 197, pp. 549 - 550, http://dx.doi.org/10.5694/mja12.11210

Hunt T; Ramanathan S; Hannaford N; Hibbert P; Braithwaite J; Coiera E; Day RO; Westbrook J; Runciman W, 2012, 'CareTrack Australia: assessing the appropriateness of adult healthcare: Protocol for a retrospective medical record review', BMJ Open, 2, pp. 665, http://dx.doi.org/10.1136/bmjopen-2011-000665

Runciman W; Hunt T; Hannaford N; Hibbert P; Westbrook J; Coiera E; Hindmarsh D; Day RO; Mcglynn EA; Braithwaite J, 2012, 'CareTrack: Assessing the appropriateness of health care delivery in Australia', Medical Journal of Australia, 197, pp. 100 - 105, http://dx.doi.org/10.5694/mja12.10510

Baysari MT; Day RO; Westbrook J, 2012, 'Consistency or efficiency? A dilemma for designers', Journal of the American Medical Informatics Association, 19, pp. 1119 - 1120, http://dx.doi.org/10.1136/amiajnl-2012-001254

Lipworth WL; Ho K; Kerridge IH; Day RO, 2012, 'Drug policy at the margins: The case of growth hormone replacement for adults with severe growth hormone deficiency', Medical Journal of Australia, 197, pp. 204 - 205, http://dx.doi.org/10.5694/mja11.11572

Westbrook J; Reckmann M; Li L; Runciman W; Burke R; Lo C; Baysari MT; Braithwaite J; Day RO, 2012, 'Effects of two commercial electronic prescribing systems on prescribing error rates in hospital inpatients: a before and after study', PLOS Medicine, 9, pp. e1001164, http://dx.doi.org/10.1371/journal.pmed.1001164

Lipworth WL; Kerridge IH; Little M; Day RO, 2012, 'Evidence and desperation in off-label prescribing: Recombinant factor VIIa', British Medical Journal: International, 344, pp. d7926, http://dx.doi.org/10.1136/bmj.d7926

Baysari MT; Reckmann M; Li L; Day RO; Westbrook J, 2012, 'Failure to utilize functions of an electronic prescribing system and the subsequent generation of 'technically preventable' computerized alerts', Journal of the American Medical Informatics Association, 19, pp. 1003 - 1010, http://dx.doi.org/10.1136/amiajnl-2011-000730

Kannangara DRW; Ramasamy SN; Indraratna P; Stocker S; Graham GG; Jones G; Portek I; Williams KM; Day RO, 2012, 'Fractional clearance of urate: Validation of measurement in spot urine samples in healthy subjects and gouty patients', Arthritis Research and Therapy, 14, pp. R189 - R197, http://dx.doi.org/10.1186/ar4020

Baysari MT; Tang T; Brett J; Day RO, 2012, 'Implementation of revised aminoglycoside guidelines: Australian hospitals 'left in the lurch'', Journal of Pharmacy Practice and Research, 42, pp. 178 - 179

Lee M-H; Stocker S; Anderson JM; Phillips EJ; Nolan DL; Williams KM; Graham GG; Sullivan JR; Day RO, 2012, 'Initiating allopurinol therapy: Do we need to know the patient's human leucocyte antigen status?', Internal Medicine Journal, 42, pp. 411 - 416, http://dx.doi.org/10.1111/j.1445-5994.2011.02567.x

Dunn AG; Day RO; Mandl K; Coiera E, 2012, 'Learning from Hackers: Open-Source Clinical Trials', Science Translational Medicine, 4, pp. 132cm5, http://stm.sciencemag.org/cgi/rapidpdf/4/132/132cm5?ijkey=r6Ku/MbAUiQyE&keytype=ref&siteid=scitransmed

Duong JK; Roberts DM; Furlong TJ; Kumar SS; Greenfield JR; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2012, 'Metformin therapy in patients with chronic kidney disease', Diabetes Obesity and Metabolism, 14, pp. 963 - 965, http://dx.doi.org/10.1111/j.1463-1326.2012.01617.x

Dunn AG; Braithwaite J; Gallego B; Day RO; Runciman W; Coiera E, 2012, 'Nation-scale adoption of new medicines by doctors: an application of the Bass diffusion model', BMC health services research, 12, pp. 248 - 248, http://dx.doi.org/10.1186/1472-6963-12-248

Ghinea N; Lipworth WL; Kerridge IH; Day RO, 2012, 'No evidence or no alternative? Taking responsibility for off-label prescribing', Internal Medicine Journal, 42, pp. 247 - 251, http://dx.doi.org/10.1111/j.1445-5994.2012.02713.x

Kannangara D; Roberts DM; Furlong TJ; Graham GG; Williams K; Day RO, 2012, 'Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease', British Journal of Clinical Pharmacology, 73, pp. 828 - 829, http://dx.doi.org/10.1111/j.1365-2125.2011.04147.x

Day RO; Kannangara DRW; Hayes JM; Furlong TJ, 2012, 'Successful use of allopurinol in a patient on dialysis', BMJ Case Reports, 2012, pp. 1 - 3, http://dx.doi.org/10.1136/bcr.02.2012.5814

Stocker S; Mclachlan AJ; Savic RM; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2012, 'The pharmacokinetics of oxypurinol in people with gout', British Journal of Clinical Pharacology, 74, pp. 477 - 489, http://dx.doi.org/10.1111/j.1365-2125.2012.04207.x

Dunn AG; Bourgeois F; Murthy S; Mandl K; Day RO; Coiera E, 2012, 'The role and impact of research agendas on the comparative effectiveness research amongst anti-hyperlipidemics', Clinical Pharmacology and Therapeutics, 91, pp. 685 - 691, http://dx.doi.org/10.1038/clpt.2011.279

Lipworth WL; Kerridge IH; Day RO, 2012, 'Time for the Pharmaceutical Benefits Advisory Committee to set its own agenda', Medical Journal of Australia, 196, pp. 374 - 375

Runciman WB; Coiera E; Day RO; Hannaford NA; Hibbert PD; Hunt T; Westbrook JI; Braithwaite J, 2012, 'Towards the delivery appropriate healthcare in Australia', Medical Journal of Australia, 197, pp. 78 - 81, http://dx.doi.org/10.5694/mja12.10799

Baysari MT; Westbrook J; Day RO, 2012, 'Understanding doctors perceptions of their prescribing competency and the value they ascribe to an electronic prescribing system', Studies in Health Technology and Informatics,Volume 178: Health Informatics: Building a Healthcare Future Through Trusted Information, 178, pp. 1 - 6, http://dx.doi.org/10.3233/978-1-61499-078-9-1

Lipworth WL; Kerridge IH; Day RO, 2012, 'Wrong questions, wrong answers? Are we getting the drugs we need?', Clinical Pharmacology and Therapeutics, 91, pp. 367 - 369, http://dx.doi.org/10.1038/clpt.2011.335

Carney SL; Gazarian M; Denholm JT; Reith DM; Penhall RK; Jenkins CR; Wilhelm KA; Komesaroff PA; Osborn MM; Day RO, 2011, 'What's in a name? Brand name confusion and generic medicines', Medical Journal of Australia, 195, pp. 650 - 651, http://dx.doi.org/10.5694/mja10.10968

Inam S; Lipworth WL; Kerridge IH; Day RO, 2011, 'Rethinking the discordance between guidelines and practice in rheumatoid arthritis treatment', Medical Journal of Australia, 195, pp. 446 - 447, http://dx.doi.org/10.5694/mja11.10068

Day R; Pomerantz P, 2011, 'Thomas W. Teal In Memoriam', DRUG INFORMATION JOURNAL, 45, pp. II - II, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000292237400001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ramasamy S; Kannangara D; Indraratna P; Stocker S; Jones G; Graham G; Williams K; Day R, 2011, 'ESTABLISHING THE USEFULNESS OF A SPOT URINE COLLECTION IN CALCULATING THE FRACTIONAL RENAL CLEARANCE OF URATE (FCU)', INTERNAL MEDICINE JOURNAL, 41, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kannangara D; Datta I; Indraratna P; Stocker S; Portek I; Graham G; Williams K; Day R, 2011, 'INDIVIDUALISING ALLOPURINOL THERAPY IN GOUT', INTERNAL MEDICINE JOURNAL, 41, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smith MWH; Roberts DM; Ritson SM; Day RO, 2011, 'Death and morbidity from supratherapeutic dosing of colchicine', Medical Journal of Australia, 194, pp. 612 - 613, http://dx.doi.org/10.5694/j.1326-5377.2011.tb03121.x

Milder T; Lipworth WL; Williams KM; Ritchie JE; Day RO, 2011, '"It looks after me": how older patients make decisions about analgesics for osteoarthritis.', Arthritis Care and Research, 63, pp. 1280 - 1286, http://dx.doi.org/10.1002/acr.20514

Roberts DM; Smith MA; McMullan B; Sevastos J; Day RO, 2011, 'Acute kidney injury due to crystalluria following acute valacycolvir overdose', Kidney International, 79, pp. 574 - 575, http://dx.doi.org/10.1038/ki.2010.496

Graham GG; Punt J; Manit A; Day RO; Doogue MP; Duong JK; Furlong TJ; Greenfield JR; Greenup L; Carl m kirkpatrick CM; Ray J; Timmins P; Williams KM, 2011, 'Clinical pharmacokinetics of metforim', Clinical Pharmacokinetics, 50, pp. 81 - 98, http://dx.doi.org/10.2165/11534750-000000000-00000

Henneicke H; Herrmann M; Kalak R; Brennan-Speranza TC; Heinevetter U; Bertollo N; Day RE; Huscher D; Buttgereit F; Dunstan CR; Seibel MJ; Zhou H, 2011, 'Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism', Bone, 49, pp. 733 - 742, http://dx.doi.org/10.1016/j.bone.2011.06.013

Roberts DM; Smith MA; Ritson R; Day RO, 2011, 'Death and morbidity from supratherapeutic dosing of colchicine: 3 cases over 2 weeks', Medical Journal of Australia, 194, pp. 612 - 613

Day RO; Lipworth WL; Kerridge IH, 2011, 'Death of the ‘Blockbuster’ and ‘Pivotal’ Clinical Trial: Rethinking the Drug Development Process.', Journal of Pharmacy Practice and Research, 41, pp. 94 - 95, http://search.informit.com.au/documentSummary;dn=210193844187640;res=IELHEA

Wang N; Lipworth WL; Ritchie JE; Williams K; Day RO, 2011, 'Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines', Internal Medicine Journal, 41, pp. 314 - 320, http://dx.doi.org/10.1111/j.1445-5994.2010.02239.x

Roberts DM; Smith MA; Gopalakrishnan M; Whittaker G; Day RO, 2011, 'Extreme y-butyrolactone overdose with severe metabolic acidosis requiring hemodialysis', Annals of Emergency Medicine, 58, pp. 83 - 85, http://dx.doi.org/10.1016/j.annemergmed.2011.01.017

Lipworth WL; Kerridge IH; Brett J; Day RO, 2011, 'How clinical and resaerch failures lead to suboptimal prescribing: the example of chronic gout', British Medical Journal, 343, pp. 1 - 3

Lipworth WL; Kerridge I; Brett J; Day R, 2011, 'How clinical and research failures lead to suboptimal prescribing: the example of chronic gout.', British Medical Journal, 343, pp. d7459, http://dx.doi.org/10.1136/bmj.d7459

Day RO; Roffe D; Richardson K; Baysari MT; Brennan NJ; Beveridge AH; Melocco T; Ainge J; Westbrook J, 2011, 'Implementing electronic medication management at an Australian teaching hospital', Medical Journal of Australia, 195, pp. 498 - 502, http://dx.doi.org/10.5694/mja11.10451

Ng DY; Stocker SL; Graham GG; Williams KM; Day RO, 2011, 'Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers', European Journal of Clinical Pharmacology, 67, pp. 709 - 713, http://dx.doi.org/10.1007/s00228-010-0963-6

Sklar P; Ripke S; Scott LJ; Andreassen OA; Cichon S; Craddock N; Edenberg HJ; Nurnberger JI; Rietschel M; Blackwood D; Corvin A; Flickinger M; Guan W; Mattingsdal M; McQuillan A; Kwan P; Wienker TF; Daly MJ; Dudbridge F; Holmans PA; Lin D; Burmeister M; Greenwood TA; Hamshere ML; Muglia P; Smith EN; Zandi PP; Nievergelt CM; McKinney R; Shilling PD; Schork NJ; Bloss CS; Foroud T; Koller DL; Gershon ES; Liu C; Badner JA; Scheftner WA; Lawson WB; Nwulia EA; Hipolito M; Coryell W; Rice J; Byerley W; McMahon FJ; Schulze TG; Berrettini W; Lohoff FW; Potash JB; Mahon AP; McInnis MG; Zollner S; Zhang P; Craig DW; Szelinger S; Barrett TB; Breuer R; Meier S; Strohmaier J; Witt SH; Tozzi F; Farmer A; McGuffin P; Strauss J; Xu W; Kennedy JL; Vincent JB; Matthews K; Day R; Ferreira MA; O'Dushlaine C; Perlis R; Raychaudhuri S; Ruderfer D; Hyoun PL; Smoller JW; Li J; Absher D; Thompson RC; Meng FG; Schatzberg A; Bunney WE; Barchas JD; Jones EG; Watson SJ; Myers RM; Akil H; Boehnke M; Chambert K; Moran J; Scolnick EM; Djurovic S; Melle I; Morken G; Gill M; Morris D; Quinn E; Muhleisen TW; Degenhardt FA; Mattheisen M; Schumacher J; Maier W; Steffens M; Propping P; Nothen MM; Anjorin A; Bass N; Gurling H; Kandaswamy R; Lawrence J; McGhee K; McIntosh A; McLean AW; Muir WJ; Pickard BS; Breen G; St Clair D; Caesar S; Gordon-Smith K; Jones L; Fraser C; Green EK; Grozeva D; Jones IR; Kirov G; Moskvina V; Nikolov I; O'Donovan MC; Owens MJ; Collier DA; Elkin A; Williamson R; Young AH; Ferrier IN; Stefansson K; Stefansson H; Porgeirsson P; Steinberg S; Gustafsson O; Bergen SE; Nimgaonkar V; Hultman C; Landen M; Lichtenstein P; Sullivan P; Schalling M; Osby U; Backlund L; Frisen L; Langstrom N; Jamain S; Leboyer M; Etain B; Bellivier F; Petursson H; Sigurgosson E; Muller-Mysok B; Lucae S; Schwarz M; Schofield PR; Martin N; Montgomery GW; Lathrop M; Oskarsson H; Bauer M; Wright A; Mitchell PB; Hautzinger M; Reif A; Kelsoe JR; Purcell SM, 2011, 'Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4', Nature Genetics, 43, pp. 977 - 985, http://dx.doi.org/10.1038/ng.943

Back to profile page